{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:59:47Z","timestamp":1779375587790,"version":"3.53.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871277"],"award-info":[{"award-number":["81871277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871277"],"award-info":[{"award-number":["81871277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871277"],"award-info":[{"award-number":["81871277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871277"],"award-info":[{"award-number":["81871277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871277"],"award-info":[{"award-number":["81871277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871277"],"award-info":[{"award-number":["81871277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871277"],"award-info":[{"award-number":["81871277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01136-8","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T15:01:57Z","timestamp":1689606117000},"page":"2997-3009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Progress in research on mesenchymal stem cells and their extracellular vesicles for treating fibrosis in systemic sclerosis"],"prefix":"10.1007","volume":"23","author":[{"given":"Yu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"issue":"10103","key":"1136_CR1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet (London, England). 2017;390(10103):1685\u201399.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"1136_CR2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","volume":"87","author":"R Jerjen","year":"2022","unstructured":"Jerjen R, Nikpour M, Krieg T, et al. Systemic sclerosis in adults. Part I: clinical features and pathogenesis. J Am Acad Dermatol. 2022;87(5):937\u201354.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1136_CR3","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","volume":"60","author":"M Bairkdar","year":"2021","unstructured":"Bairkdar M, Rossides M, Westerlind H, et al. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(7):3121\u201333.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1136_CR4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","volume":"51","author":"M Elhai","year":"2012","unstructured":"Elhai M, Meune C, Avouac J, et al. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2012;51(6):1017\u201326.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1136_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2010.48","volume":"6","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals M, Fonollosa-Pla V, Brito-Zer\u00f3n P, et al. Targeted therapy for systemic sclerosis: how close are we? Nat Rev Rheumatol. 2010;6(5):269\u201378.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1136_CR6","doi-asserted-by":"crossref","first-page":"101671","DOI":"10.1016\/j.berh.2021.101671","volume":"35","author":"M Martin-Lopez","year":"2021","unstructured":"Martin-Lopez M, Carreira PE. Antifibrotics in systemic sclerosis. Best Pract Res Clin Rheumatol. 2021;35(3):101671.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"1136_CR7","doi-asserted-by":"crossref","first-page":"102730","DOI":"10.1016\/j.autrev.2020.102730","volume":"20","author":"C Varrica","year":"2021","unstructured":"Varrica C, Dias HS, Reis C, et al. Targeted delivery in scleroderma fibrosis. Autoimmun Rev. 2021;20(2):102730.","journal-title":"Autoimmun Rev"},{"key":"1136_CR8","doi-asserted-by":"crossref","first-page":"728190","DOI":"10.3389\/fimmu.2021.728190","volume":"12","author":"A Li","year":"2021","unstructured":"Li A, Guo F, Pan Q, et al. Mesenchymal stem cell therapy: hope for patients with systemic lupus erythematosus. Front Immunol. 2021;12:728190.","journal-title":"Front Immunol"},{"issue":"2","key":"1136_CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12016-012-8347-6","volume":"45","author":"J Voswinkel","year":"2013","unstructured":"Voswinkel J, Francois S, Simon JM, et al. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Clin Rev Allergy Immunol. 2013;45(2):180\u201392.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"1136_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12015-011-9345-4","volume":"9","author":"F Casiraghi","year":"2013","unstructured":"Casiraghi F, Remuzzi G, Abbate M, et al. Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem Cell Rev Rep. 2013;9(1):65\u201379.","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"1136_CR11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2015.44","volume":"23","author":"S Rani","year":"2015","unstructured":"Rani S, Ryan AE, Griffin MD, et al. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther. 2015;23(5):812\u201323.","journal-title":"Mol Ther"},{"issue":"6","key":"1136_CR12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/stem.1681","volume":"32","author":"FJ Lv","year":"2014","unstructured":"Lv FJ, Tuan RS, Cheung KM, et al. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells. 2014;32(6):1408\u201319.","journal-title":"Stem Cells"},{"issue":"6","key":"1136_CR13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau J, Sens\u00e9b\u00e9 L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824\u201333.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"1136_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/scrt214","volume":"4","author":"C M\u00e9nard","year":"2013","unstructured":"M\u00e9nard C, Tarte K. Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application. Stem Cell Res Ther. 2013;4(3):64.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"1136_CR15","first-page":"267","volume":"4","author":"AJ Friedenstein","year":"1976","unstructured":"Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4(5):267\u201374.","journal-title":"Exp Hematol"},{"issue":"6","key":"1136_CR16","first-page":"1684","volume":"23","author":"SL Zhou","year":"2015","unstructured":"Zhou SL, Zheng C, Su JQ, et al. Isolation and identification of human umbilical cord and placenta-derived stem cells and their component analysis. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015;23(6):1684\u201391.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"1136_CR17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13287-021-02222-y","volume":"12","author":"M Mebarki","year":"2021","unstructured":"Mebarki M, Abadie C, Larghero J, et al. Human umbilical cord-derived mesenchymal stem\/stromal cells: a promising candidate for the development of advanced therapy medicinal products. Stem Cell Res Ther. 2021;12(1):152.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1136_CR18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","volume":"129","author":"B Puissant","year":"2005","unstructured":"Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol. 2005;129(1):118\u201329.","journal-title":"Br J Haematol"},{"issue":"1","key":"1136_CR19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/stem.3077","volume":"38","author":"C M\u00e9nard","year":"2020","unstructured":"M\u00e9nard C, Dulong J, Roulois D, et al. Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells. Stem Cells. 2020;38(1):146\u201359.","journal-title":"Stem Cells"},{"issue":"5","key":"1136_CR20","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/stem.2580","volume":"35","author":"S Loisel","year":"2017","unstructured":"Loisel S, Dulong J, M\u00e9NARD C, et al. Brief report: proteasomal indoleamine 2,3-dioxygenase degradation reduces the immunosuppressive potential of clinical grade-mesenchymal stromal cells undergoing replicative senescence. Stem Cells. 2017;35(5):1431\u20136.","journal-title":"Stem Cells"},{"issue":"8","key":"1136_CR21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, Wang Y, Li Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493\u2013507.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"1136_CR22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/scrt55","volume":"2","author":"M Maumus","year":"2011","unstructured":"Maumus M, Gu\u00e9rit D, Toupet K, et al. Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Stem Cell Res Ther. 2011;2(2):14.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"1136_CR23","doi-asserted-by":"crossref","first-page":"102755","DOI":"10.1016\/j.autrev.2021.102755","volume":"20","author":"D Farge","year":"2021","unstructured":"Farge D, Loisel S, Lansiaux P, et al. Mesenchymal stromal cells for systemic sclerosis treatment. Autoimmun Rev. 2021;20(3):102755.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1136_CR24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.apjtm.2016.10.005","volume":"10","author":"W Chen","year":"2017","unstructured":"Chen W, Xia ZK, Zhang MH, et al. Adipose tissue-derived stem cells ameliorates dermal fibrosis in a mouse model of scleroderma. Asian Pac J Trop Med. 2017;10(1):52\u20136.","journal-title":"Asian Pac J Trop Med"},{"issue":"6","key":"1136_CR25","first-page":"257","volume":"20","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zhu S, Li Y, et al. Human umbilical cord mesenchymal stem cells ameliorate skin fibrosis development in a mouse model of bleomycin-induced systemic sclerosis. Exp Ther Med. 2020;20(6):257.","journal-title":"Exp Ther Med"},{"issue":"6","key":"1136_CR26","doi-asserted-by":"crossref","first-page":"e0196048","DOI":"10.1371\/journal.pone.0196048","volume":"13","author":"G Moroncini","year":"2018","unstructured":"Moroncini G, Paolini C, Orlando F, et al. Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice. PLoS ONE. 2018;13(6):e0196048.","journal-title":"PLoS ONE"},{"issue":"1","key":"1136_CR27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-022-02915-6","volume":"24","author":"T Suzuka","year":"2022","unstructured":"Suzuka T, Kotani T, Saito T, et al. Therapeutic effects of adipose-derived mesenchymal stem\/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis. Arthritis Res Ther. 2022;24(1):228.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1136_CR28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13287-021-02400-y","volume":"12","author":"J Jin","year":"2021","unstructured":"Jin J, Ou Q, Wang Z, et al. BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs. Stem Cell Res Ther. 2021;12(1):327.","journal-title":"Stem Cell Res Ther"},{"issue":"19","key":"1136_CR29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/scd.2021.0112","volume":"30","author":"M Li","year":"2021","unstructured":"Li M, Zhang HP, Wang XY, et al. Mesenchymal stem cell-derived exosomes ameliorate dermal fibrosis in a murine model of bleomycin-induced scleroderma. Stem Cells Dev. 2021;30(19):981\u201390.","journal-title":"Stem Cells Dev"},{"issue":"4","key":"1136_CR30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.39477","volume":"68","author":"AT Maria","year":"2016","unstructured":"Maria AT, Toupet K, Bony C, et al. Antifibrotic, antioxidant, and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis. Arthritis Rheumatol (Hoboken, NJ). 2016;68(4):1013\u201325.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"1136_CR31","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3389\/fimmu.2018.02571","volume":"9","author":"ATJ Maria","year":"2018","unstructured":"Maria ATJ, Toupet K, Maumus M, et al. Fibrosis development in HOCl-induced systemic sclerosis: a multistage process hampered by mesenchymal stem cells. Front Immunol. 2018;9:2571.","journal-title":"Front Immunol"},{"issue":"3","key":"1136_CR32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.15283\/ijsc20002","volume":"14","author":"X Jin","year":"2021","unstructured":"Jin X, Hou J, Zheng K, et al. Umbilical cord mesenchymal stem cells for inhibiting the fibrosis and autoimmune development in HOCl-induced systemic scleroderma mouse model. Int J Stem Cells. 2021;14(3):262\u201374.","journal-title":"Int J Stem Cells"},{"key":"1136_CR33","doi-asserted-by":"crossref","first-page":"101671","DOI":"10.1016\/j.tice.2021.101671","volume":"73","author":"DF Elessawi","year":"2021","unstructured":"Elessawi DF, Gabr H, Badawy MMM, et al. Therapeutic potential of mesenchymal stem cells for scleroderma induced in mouse model. Tissue Cell. 2021;73:101671.","journal-title":"Tissue Cell"},{"key":"1136_CR34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2016.03.013","volume":"70","author":"AT Maria","year":"2016","unstructured":"Maria AT, Toupet K, Maumus M, et al. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis. J Autoimmun. 2016;70:31\u20139.","journal-title":"J Autoimmun"},{"issue":"5","key":"1136_CR35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama K, Chen C, Wang D, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis. Cell Stem Cell. 2012;10(5):544\u201355.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"1136_CR36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/cr.2017.11","volume":"27","author":"C Chen","year":"2017","unstructured":"Chen C, Wang D, Moshaverinia A, et al. Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis. Cell Res. 2017;27(4):559\u201377.","journal-title":"Cell Res"},{"issue":"9","key":"1136_CR37","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.jid.2017.02.986","volume":"137","author":"JY Lim","year":"2017","unstructured":"Lim JY, Ryu DB, Lee SE, et al. Mesenchymal stem cells (MSCs) attenuate cutaneous sclerodermatous graft-versus-host disease (Scl-GVHD) through inhibition of immune cell infiltration in a mouse model. J Invest Dermatol. 2017;137(9):1895\u2013904.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1136_CR38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1756-185X.13764","volume":"23","author":"A Okamura","year":"2020","unstructured":"Okamura A, Matsushita T, Komuro A, et al. Adipose-derived stromal\/stem cells successfully attenuate the fibrosis of scleroderma mouse models. Int J Rheum Dis. 2020;23(2):216\u201325.","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"1136_CR39","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.transproceed.2008.01.080","volume":"40","author":"F Zhao","year":"2008","unstructured":"Zhao F, Zhang YF, Liu YG, et al. Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant Proc. 2008;40(5):1700\u20135.","journal-title":"Transplant Proc"},{"issue":"1","key":"1136_CR40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2353\/ajpath.2009.080629","volume":"175","author":"Y Moodley","year":"2009","unstructured":"Moodley Y, Atienza D, Manuelpillai U, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 2009;175(1):303\u201313.","journal-title":"Am J Pathol"},{"issue":"6","key":"1136_CR41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/iwj.12034","volume":"11","author":"Y Wu","year":"2014","unstructured":"Wu Y, Huang S, Enhe J, et al. Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice. Int Wound J. 2014;11(6):701\u201310.","journal-title":"Int Wound J"},{"issue":"4","key":"1136_CR42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","volume":"112","author":"T Yamamoto","year":"1999","unstructured":"Yamamoto T, Takagawa S, Katayama I, et al. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol. 1999;112(4):456\u201362.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"1136_CR43","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/art.27647","volume":"62","author":"C Beyer","year":"2010","unstructured":"Beyer C, Schett G, Distler O, et al. Animal models of systemic sclerosis: prospects and limitations. Arthritis Rheum. 2010;62(10):2831\u201344.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1136_CR44","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.5966\/sctm.2015-0337","volume":"5","author":"EF Cahill","year":"2016","unstructured":"Cahill EF, Kennelly H, Carty F, et al. Hepatocyte growth factor is required for mesenchymal stromal cell protection against bleomycin-induced pulmonary fibrosis. Stem Cells Transl Med. 2016;5(10):1307\u201318.","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"1136_CR45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/jb\/mvm067","volume":"141","author":"R Sakiyama","year":"2007","unstructured":"Sakiyama R, Fukuta K, Matsumoto K, et al. Stimulation of hepatocyte growth factor production by heparin-derived oligosaccharides. J Biochem. 2007;141(5):653\u201360.","journal-title":"J Biochem"},{"issue":"9","key":"1136_CR46","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","volume":"182","author":"A Servettaz","year":"2009","unstructured":"Servettaz A, Goulvestre C, Kavian N, et al. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol. 2009;182(9):5855\u201364.","journal-title":"J Immunol"},{"issue":"3","key":"1136_CR47","first-page":"493","volume":"82","author":"MC Green","year":"1976","unstructured":"Green MC, Sweet HO, Bunker LE. Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol. 1976;82(3):493\u2013512.","journal-title":"Am J Pathol"},{"issue":"3","key":"1136_CR48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389-401.e1.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"1136_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(83)90001-1","volume":"77","author":"BD Jaffee","year":"1983","unstructured":"Jaffee BD, Claman HN. Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol. 1983;77(1):1\u201312.","journal-title":"Cell Immunol"},{"issue":"9","key":"1136_CR50","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/2211-5463.12268","volume":"7","author":"X Yang","year":"2017","unstructured":"Yang X, Liu C, Fujino M, et al. A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice. FEBS Open Bio. 2017;7(9):1316\u201327.","journal-title":"FEBS Open Bio"},{"issue":"1","key":"1136_CR51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0008-8749(85)90086-3","volume":"94","author":"HN Claman","year":"1985","unstructured":"Claman HN, Jaffee BD, Huff JC, et al. Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol. 1985;94(1):73\u201384.","journal-title":"Cell Immunol"},{"issue":"5","key":"1136_CR52","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.leu.2404996","volume":"22","author":"M Christopeit","year":"2008","unstructured":"Christopeit M, Schendel M, F\u00f6LL J, et al. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia. 2008;22(5):1062\u20134.","journal-title":"Leukemia"},{"issue":"8","key":"1136_CR53","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/art.30431","volume":"63","author":"G Keyszer","year":"2011","unstructured":"Keyszer G, Christopeit M, Fick S, et al. Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases. Arthritis Rheum. 2011;63(8):2540\u20132.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1136_CR54","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","volume":"153","author":"S Guiducci","year":"2010","unstructured":"Guiducci S, Porta F, Saccardi R, et al. Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report. Ann Intern Med. 2010;153(10):650\u20134.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1136_CR55","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3727\/096368912X639017","volume":"22","author":"N Scuderi","year":"2013","unstructured":"Scuderi N, Ceccarelli S, Onesti MG, et al. Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplant. 2013;22(5):779\u201395.","journal-title":"Cell Transplant"},{"key":"1136_CR56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/sci.2016.09.03","volume":"3","author":"T Wehbe","year":"2016","unstructured":"Wehbe T, Abi Saab M, Abi Chahine N, et al. Mesenchymal stem cell therapy for refractory scleroderma: a report of 2 cases. Stem Cell Investig. 2016;3:48.","journal-title":"Stem Cell Investig"},{"issue":"1","key":"1136_CR57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13075-017-1373-2","volume":"19","author":"H Zhang","year":"2017","unstructured":"Zhang H, Liang J, Tang X, et al. Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis. Arthritis Res Ther. 2017;19(1):165.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1136_CR58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s13287-022-03127-0","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Cai J, Zhang Q, et al. Fat transplantation induces dermal adipose regeneration and reverses skin fibrosis through dedifferentiation and redifferentiation of adipocytes. Stem Cell Res Ther. 2022;13(1):499.","journal-title":"Stem Cell Res Ther"},{"key":"1136_CR59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13075-015-0819-7","volume":"17","author":"A Cras","year":"2015","unstructured":"Cras A, Farge D, Carmoi T, et al. Update on mesenchymal stem cell-based therapy in lupus and scleroderma. Arthritis Res Ther. 2015;17:301.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1136_CR60","doi-asserted-by":"crossref","first-page":"v44","DOI":"10.1093\/rheumatology\/ken309","volume":"47","author":"L Czirj\u00e1k","year":"2008","unstructured":"Czirj\u00e1k L, Foeldvari I, M\u00fcller-Ladner U. Skin involvement in systemic sclerosis. Rheumatology (Oxford). 2008;47(5):v44\u20135.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1136_CR61","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13287-022-02786-3","volume":"13","author":"J Cui","year":"2022","unstructured":"Cui J, Jin L, Ding M, et al. Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis. Stem Cell Res Ther. 2022;13(1):118.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1136_CR62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ijms.21666","volume":"15","author":"V Volarevic","year":"2018","unstructured":"Volarevic V, Markovic BS, Gazdic M, et al. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 2018;15(1):36\u201345.","journal-title":"Int J Med Sci"},{"issue":"13","key":"1136_CR63","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.7150\/thno.40122","volume":"10","author":"S Varderidou-Minasian","year":"2020","unstructured":"Varderidou-Minasian S, Lorenowicz MJ. Mesenchymal stromal\/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities. Theranostics. 2020;10(13):5979\u201397.","journal-title":"Theranostics"},{"issue":"4","key":"1136_CR64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1136_CR65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"S Keshtkar","year":"2018","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9(1):63.","journal-title":"Stem Cell Res Ther"},{"issue":"13","key":"1136_CR66","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.3390\/ijms22136837","volume":"22","author":"P Rozier","year":"2021","unstructured":"Rozier P, Maumus M, Bony C, et al. Extracellular vesicles are more potent than adipose mesenchymal stromal cells to exert an anti-fibrotic effect in an in vitro model of systemic sclerosis. Int J Mol Sci. 2021;22(13):6834.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1136_CR67","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851\u20138.","journal-title":"Stem Cells"},{"issue":"10","key":"1136_CR68","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s42255-021-00467-8","volume":"3","author":"E Milbank","year":"2021","unstructured":"Milbank E, Dragano NRV, Gonz\u00e1lez-Garc\u00eda I, et al. Small extracellular vesicle-mediated targeting of hypothalamic AMPK\u03b11 corrects obesity through BAT activation. Nat Metab. 2021;3(10):1415\u201331.","journal-title":"Nat Metab"},{"issue":"1","key":"1136_CR69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12929-021-00725-7","volume":"28","author":"WZ Zhuang","year":"2021","unstructured":"Zhuang WZ, Lin YH, Su LJ, et al. Mesenchymal stem\/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci. 2021;28(1):28.","journal-title":"J Biomed Sci"},{"issue":"7","key":"1136_CR70","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021;16(7):748\u201359.","journal-title":"Nat Nanotechnol"},{"key":"1136_CR71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semcdb.2019.10.014","volume":"101","author":"JS Rockel","year":"2020","unstructured":"Rockel JS, Rabani R, Viswanathan S. Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases. Semin Cell Dev Biol. 2020;101:87\u2013103.","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"1136_CR72","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3390\/cells10102727","volume":"10","author":"P Rozier","year":"2021","unstructured":"Rozier P, Maumus M, Maria ATJ, et al. Lung fibrosis Is improved by extracellular vesicles from IFN\u03b3-primed mesenchymal stromal cells in murine systemic sclerosis. Cells. 2021;10(10):2727.","journal-title":"Cells"},{"key":"1136_CR73","doi-asserted-by":"crossref","first-page":"102660","DOI":"10.1016\/j.jaut.2021.102660","volume":"121","author":"P Rozier","year":"2021","unstructured":"Rozier P, Maumus M, Maria ATJ, et al. Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p. J Autoimmun. 2021;121:102660.","journal-title":"J Autoimmun"},{"issue":"1","key":"1136_CR74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jdermsci.2021.08.006","volume":"104","author":"H Baral","year":"2021","unstructured":"Baral H, Uchiyama A, Yokoyama Y, et al. Antifibrotic effects and mechanisms of mesenchymal stem cell-derived exosomes in a systemic sclerosis mouse model: possible contribution of miR-196b-5p. J Dermatol Sci. 2021;104(1):39\u201347.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"1136_CR75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13770-021-00405-5","volume":"19","author":"Y Yu","year":"2022","unstructured":"Yu Y, Shen L, Xie X, et al. The therapeutic effects of exosomes derived from human umbilical cord mesenchymal stem cells on scleroderma. Tissue Eng Regen Med. 2022;19(1):141\u201350.","journal-title":"Tissue Eng Regen Med"},{"key":"1136_CR76","doi-asserted-by":"crossref","first-page":"106541","DOI":"10.1016\/j.intimp.2020.106541","volume":"84","author":"L Guo","year":"2020","unstructured":"Guo L, Lai P, Wang Y, et al. Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response. Int Immunopharmacol. 2020;84:106541.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"1136_CR77","doi-asserted-by":"crossref","first-page":"e0181946","DOI":"10.1371\/journal.pone.0181946","volume":"12","author":"KE Hostettler","year":"2017","unstructured":"Hostettler KE, Gazdhar A, Khan P, et al. Multipotent mesenchymal stem cells in lung fibrosis. PLoS ONE. 2017;12(8):e0181946.","journal-title":"PLoS ONE"},{"issue":"7","key":"1136_CR78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11926-019-0831-z","volume":"21","author":"DM Toledo","year":"2019","unstructured":"Toledo DM, Pioli PA. Macrophages in systemic sclerosis: novel insights and therapeutic implications. Curr Rheumatol Rep. 2019;21(7):31.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"1136_CR79","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13287-022-02875-3","volume":"13","author":"DP Sarvar","year":"2022","unstructured":"Sarvar DP, Effatpanah H, Akbarzadehlaleh P, et al. Mesenchymal stromal cell-derived extracellular vesicles: novel approach in hematopoietic stem cell transplantation. Stem Cell Res Ther. 2022;13(1):202.","journal-title":"Stem Cell Res Ther"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01136-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01136-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01136-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:27:54Z","timestamp":1698784074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01136-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":79,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01136-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"assertion":[{"value":"30 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the authors approved the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}